Welcome on board!
This is a very important moment for us, which will further strengthen our drug discovery expertise in the field of DNA Damage Response and beyond!
https://www.icr.ac.uk/our-research/researchers-and-teams/dr-wojciech-niedzwiedz
Professor Wojciech Niedzwiedz from the Institute of Cancer Research and one of the top leaders in the field, is joining our Scientific Advisory Board.
Welcome on board!
This is a very important moment for us, which will further strengthen our drug discovery expertise in the field of DNA Damage Response and beyond!
https://www.icr.ac.uk/our-research/researchers-and-teams/dr-wojciech-niedzwiedz
We are very happy to announce that our abstract and related publication titled “Random similarity forests” has been accepted at this year’s European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases- #ECMLPKDD2022!
Breast cancer (BC) constitutes the most common female malignancy and nowadays molecular classification of subtypes is crucial to estimate a patient’s prognosis and administer appropriate treatment. It allows tailoring therapeutic strategy much more precisely than using a standalone IHC status.